Mark Pruzanski

Insider Reports History

Location
New York, NY
Signature
/s/ Daniel M. Bradbury, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Pruzanski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Equillium, Inc. Director Director Stock Option (right to buy) 20,000 21 May 2025 Direct
Equillium, Inc. Director Stock Option (right to buy) 20,000 22 May 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct

Insider Reports Filed by Mark Pruzanski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EQ Equillium, Inc. 21 May 2025 1 $0 4 Director 23 May 2025, 13:45
EQ Equillium, Inc. 14 Feb 2025 8 $0 4 Director 19 Feb 2025, 19:39
EQ Equillium, Inc. 22 May 2024 1 $0 4 Director 23 May 2024, 18:02
/report/000110465923117094-pruzanski-mark-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 14 -$11,758,986 4 Director 13 Nov 2023, 14:40
EQ Equillium, Inc. 22 May 2023 1 $0 4 Director 23 May 2023, 18:04
EQ Equillium, Inc. 24 May 2022 1 $0 4 Director 25 May 2022, 19:54
/report/000110465921145908-pruzanski-mark-2021-11-30 INTERCEPT PHARMACEUTICALS, INC. 30 Nov 2021 2 +$39,944 4 Director 02 Dec 2021, 15:05
/report/000110465921132983-pruzanski-mark-2021-10-29 INTERCEPT PHARMACEUTICALS, INC. 29 Oct 2021 2 +$39,132 4 Director 02 Nov 2021, 16:01
/report/000110465921122560-pruzanski-mark-2021-09-30 INTERCEPT PHARMACEUTICALS, INC. 30 Sep 2021 2 +$34,452 4 Director 04 Oct 2021, 17:02
/report/000110465921112144-pruzanski-mark-2021-08-31 INTERCEPT PHARMACEUTICALS, INC. 31 Aug 2021 2 +$34,606 4 Director 01 Sep 2021, 19:01
/report/000110465921099031-pruzanski-mark-2021-07-30 INTERCEPT PHARMACEUTICALS, INC. 30 Jul 2021 2 +$40,107 4 Director 02 Aug 2021, 19:00
/report/000110465921088399-pruzanski-mark-2021-06-30 INTERCEPT PHARMACEUTICALS, INC. 30 Jun 2021 2 +$46,330 4 Director 01 Jul 2021, 19:01
/report/000110465921075896-pruzanski-mark-2021-05-28 INTERCEPT PHARMACEUTICALS, INC. 28 May 2021 2 +$38,598 4 Director 02 Jun 2021, 19:00
EQ Equillium, Inc. 26 May 2021 1 $0 4 Director 28 May 2021, 18:18